Intelligence · Clinical Pipeline
Boehringer Ingelheim Pipeline
All ClinicalTrials.gov programs at Boehringer Ingelheim — phase, modality, and trial IDs.
- Programs
- 6
Quick answer
Boehringer Ingelheim has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Afatinib
Boehringer Ingelheim
Carcinoma, Non-Small-Cell Lung
1 trial -
Spesolimab
Boehringer Ingelheim
Generalized Pustular Psoriasis
3 trials -
Telmisartan
Boehringer Ingelheim
Cardiovascular Diseases
1 trial -
metformin
Boehringer Ingelheim
Diabetes Mellitus, Type 2
1 trial -
telmisartan
Boehringer Ingelheim
Hypertension
1 trial -
tiotropium 18 mcg
Boehringer Ingelheim
Pulmonary Disease, Chronic Obstructive
1 trial
Frequently asked questions
How many pipeline programs does Boehringer Ingelheim have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs